These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19284479)

  • 1. Expression of reticulon 3 in Alzheimer's disease brain.
    Kume H; Konishi Y; Murayama KS; Kametani F; Araki W
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):178-88. PubMed ID: 19284479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of altered RTN3 expression on BACE1 activity and Alzheimer's neuritic plaques.
    Sharoar MG; Yan R
    Rev Neurosci; 2017 Feb; 28(2):145-154. PubMed ID: 27883331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer's brains.
    Shi Q; Ge Y; He W; Hu X; Yan R
    Sci Rep; 2017 Jul; 7(1):6145. PubMed ID: 28733667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1.
    Deng M; He W; Tan Y; Han H; Hu X; Xia K; Zhang Z; Yan R
    J Biol Chem; 2013 Oct; 288(42):30236-30245. PubMed ID: 24005676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.
    Shi Q; Prior M; He W; Tang X; Hu X; Yan R
    J Neurosci; 2009 Jul; 29(29):9163-73. PubMed ID: 19625507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
    Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
    Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of RTN3 deficiency on expression of BACE1 and amyloid deposition.
    Shi Q; Ge Y; Sharoar MG; He W; Xiang R; Zhang Z; Hu X; Yan R
    J Neurosci; 2014 Oct; 34(42):13954-62. PubMed ID: 25319692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA levels of BACE1 and its interacting proteins, RTN3 and PPIL2, correlate in human post mortem brain tissue.
    Beyer N; Coulson DT; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
    Neuroscience; 2014 Aug; 274():44-52. PubMed ID: 24853053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of rare RTN3 variants in Alzheimer's disease in Han Chinese.
    Zou Y; He W; Wang K; Han H; Xiao T; Chen X; Zhou B; Tan J; Xia K; Tang B; Chen C; Shen L; Yan R; Zhang Z
    Hum Genet; 2018 Feb; 137(2):141-150. PubMed ID: 29356939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAP31 deficiency contributes to the formation of amyloid-β plaques in Alzheimer's disease by reducing the stability of RTN3.
    Wang T; Chen J; Hou Y; Yu Y; Wang B
    FASEB J; 2019 Apr; 33(4):4936-4946. PubMed ID: 30596517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein.
    Murayama KS; Kametani F; Saito S; Kume H; Akiyama H; Araki W
    Eur J Neurosci; 2006 Sep; 24(5):1237-44. PubMed ID: 16965550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.
    Carson R; McKnight AJ; Todd S; Liu WW; Heggarty S; Craig D; McGuinness B; Irvine GB; Passmore AP; Johnston JA
    Neuromolecular Med; 2009; 11(4):337-44. PubMed ID: 19669607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1.
    Kume H; Murayama KS; Araki W
    J Neurosci Res; 2009 Oct; 87(13):2963-72. PubMed ID: 19405102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation.
    He W; Lu Y; Qahwash I; Hu XY; Chang A; Yan R
    Nat Med; 2004 Sep; 10(9):959-65. PubMed ID: 15286784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of interaction domains mediating binding between BACE1 and RTN/Nogo proteins.
    He W; Hu X; Shi Q; Zhou X; Lu Y; Fisher C; Yan R
    J Mol Biol; 2006 Oct; 363(3):625-34. PubMed ID: 16979658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTN/Nogo in forming Alzheimer's neuritic plaques.
    Prior M; Shi Q; Hu X; He W; Levey A; Yan R
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1201-6. PubMed ID: 20144652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The membrane topology of RTN3 and its effect on binding of RTN3 to BACE1.
    He W; Shi Q; Hu X; Yan R
    J Biol Chem; 2007 Oct; 282(40):29144-51. PubMed ID: 17699523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reticulon 3 regulates very low density lipoprotein secretion by controlling very low density lipoprotein transport vesicle biogenesis.
    Siddiqi S; Zhelyabovska O; Siddiqi SA
    Can J Physiol Pharmacol; 2018 Jul; 96(7):668-675. PubMed ID: 29756473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing formation of reticulon 3 immunoreactive dystrophic neurites improves cognitive function in mice.
    Shi Q; Prior M; Zhou X; Tang X; He W; Hu X; Yan R
    J Neurosci; 2013 Feb; 33(7):3059-66. PubMed ID: 23407961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.